The Primary
Care Companionfor CNS Disorders

Suicide

Letter to the Editor September 26, 2019

Suicide Prevention and Schizophrenia

Steven Lippmann, MD; Bilge Togay, MD

Prim Care Companion CNS Disord 2019;21(5):19l02433

Article Abstract

Free Access: Please Log In

This content is completely free—but you need to be logged in to read the full article. If you already have an account, please log in below. Otherwise, register for free to unlock instant access.

About the Authors

Buy PDF for $40.00

Please sign in or purchase this PDF for $40.00.

Save

Cite

Read the Current Issue

Original Research

Conflict Mediation by CBT

Systematic Review

Psychiatric Adverse Effects of Hydroxychloroquine

Review Article

Efficacy of GLP-1 Agonists in Mental Disorders

Rounds in the General Hospital

Time-Limited Teaching of Psychiatry to Medical Students

Rounds in the General Hospital

Multimodal Approaches to Pain Management

Rounds in the General Hospital

Sequelae of Adverse Childhood Experiences

View current Issue

Letter to the Editor

Daridorexant: Caution Is Needed About Suicidal Risk in Depressed Patients With Insomnia—Reply to Palagini et al

July 3, 2023

Bénédicte Nobile, PharmD, PhD, and Philippe Courtet, MD, PhD, continue the discussion of potentially increased suicidal risk with daridorexant, a new hypnotic.

Philippe Courtet, Bénédicte Nobile

Letter to the Editor

Aggravation of Suicide Risk With Daridorexant: Currently Not Enough Data to Show a Link

July 3, 2023

Palagini and colleagues comment on a recent letter that suggested a role for daridorexant, a new hypnotic, in increasing suicide risk.

Dieter Riemann, Laura Palagini, Pierre A. Geoffroy, et al

Letter to the Editor

Possible Suicidal Risk With Daridorexant

December 7, 2022

Instructions for use of the new anti-insomnia medication daridorexant mention cautious use in patients with history of suicidal behavior. This letter explores the factors that underlie this recommendation for...

Philippe Courtet, Bénédicte Nobile, Emilie Olié

Suicide Prevention and Schizophrenia

About the Authors

Read the Current Issue

Conflict Mediation by CBT

Psychiatric Adverse Effects of Hydroxychloroquine

Efficacy of GLP-1 Agonists in Mental Disorders

Time-Limited Teaching of Psychiatry to Medical Students

Multimodal Approaches to Pain Management

Sequelae of Adverse Childhood Experiences

ELSEWHERE:

FOLLOW US:

Suicide Prevention and Schizophrenia

Free Access: Please Log In

About the Authors

Read the Current Issue

Conflict Mediation by CBT

Psychiatric Adverse Effects of Hydroxychloroquine

Efficacy of GLP-1 Agonists in Mental Disorders

Time-Limited Teaching of Psychiatry to Medical Students

Multimodal Approaches to Pain Management

Sequelae of Adverse Childhood Experiences

Related Articles

Daridorexant: Caution Is Needed About Suicidal Risk in Depressed Patients With Insomnia—Reply to Palagini et al

Aggravation of Suicide Risk With Daridorexant: Currently Not Enough Data to Show a Link

Possible Suicidal Risk With Daridorexant

Watch the New PsychCase360

Subscribe to readmore articles

Subscribe to read
more articles